Search Results

You are looking at 31 - 40 of 82 items for :

  • "fertility preservation" x
  • Refine by Access: All x
Clear All
Full access

Cervical Cancer

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, David Cohn, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Robert L. Giuntoli II, Ernest Han, Warner K. Huh, John R. Lurain III, Lainie Martin, Mark A. Morgan, David Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small Jr, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Nicole R. McMillian, and Miranda Hughes

dissection depends on whether pelvic nodal disease and/or LVSI is present and the size of the tumors. Fertility-Sparing: For patients who desire fertility preservation, cone biopsy with or without pelvic lymph node dissection is recommended. 73 , 74 For

Full access

Cervical Cancer, Version 2.2015

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, Kathleen R. Cho, Christina Chu, David Cohn, Marta Ann Crispens, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain III, David Mutch, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Catheryn M. Yashar, Nicole R. McMillian, and Jillian L. Scavone

procedure have been examined. Abdominal radical trachelectomy provides a broader resection of the parametria than a vaginal approach, but provides a less conservative alternative for fertility preservation. 55 , 60 Multiple case series have evaluated safety

Full access

NCCN Patient Advocacy Summit: Delivering Value for Patients Across the Oncology Ecosystem

Terrell Johnson, Lindsey A.M. Bandini, Darryl Mitteldorf, Elizabeth Franklin, Justin E. Bekelman, and Robert W. Carlson

the expansion of fertility preservation policies in state legislatures, advocates note that needs assessments for sexual health have significant room for improvement. 6 Queries of the patient community indicate that care team conversations about

Full access

Breast Cancer in Adolescents and Young Adults: A Review With a Focus on Biology

Jill R. Tichy, Elgene Lim, and Carey K. Anders

potential diagnosed with breast cancer should be educated about the risk of infertility at the earliest opportunity, offered fertility preservation, and referred to a reproductive specialist as appropriate. 51 Finally, the decision to recommend chemotherapy

Full access

NCCN News

issues that AYA patients face as critical components in delivering state-of-the-art care. The NCCN Guidelines include recommendations for fertility preservation; screening recommendations for late effects after successful completion of therapy; and

Full access

Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer

Emma Gargus, Rebecca Deans, Antoinette Anazodo, and Teresa K. Woodruff

ovarian function and fertility after cancer treatments are uncertain and that fertility preservation should be pursued as early as possible, ideally before cancer treatment, if it is desired. Various methods have been used to determine ovarian reserve in

Full access

Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Wui-Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, Rachel Clark, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian, and Jillian L. Scavone

. Primary Treatment The primary treatment of early-stage cervical cancer is either surgery or RT. Surgery is typically reserved for early-stage disease, fertility-preservation, and smaller lesions, such as stage IA, IB1, and selected IIA1 cases. 3 The

Full access

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

Robert J. Morgan Jr, Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Kian Behbakht, Lee-may Chen, Larry Copeland, Marta Ann Crispens, Maria DeRosa, Oliver Dorigo, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Sanja Percac-Lima, Mario Pineda, Steven C. Plaxe, Matthew A. Powell, Elena Ratner, Steven W. Remmenga, Peter G. Rose, Paul Sabbatini, Joseph T. Santoso, Theresa L. Werner, Jennifer Burns, and Miranda Hughes

cell tumors, borderline epithelial tumors, unilateral stage I epithelial ovarian tumors, or unilateral stage I sex cord-stromal tumors. 116 , 117 , 120 , 137 – 140 Patients who do not desire fertility preservation; those who have a clinical stage IB

Full access

Breast Cancer Version 2.2015

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead, and Rashmi Kumar

childhood illness. However, treatment for breast cancer, especially with cytotoxic agents, may impair fertility. Therefore, it is reasonable and appropriate to consider fertility preservation prior to breast cancer treatment in young women who desire to bear

Full access

Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer

Kari E. Hacker, Shitanshu Uppal, and Carolyn Johnston

invasive implants are present, especially if they are not surgically debulked ( Figure 1 ). Management Borderline Tumors BOTs are frequently diagnosed in women of childbearing age who desire fertility preservation. In studies assessing the